Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial.

Jingxin LiAi-Min HuiXiang ZhangLei GeYuanzheng QiuRong TangHuayue YeXiyuan WangMei LinZhongkui ZhuJianfei ZhengJingjun QiuEleni LagkadinouSvetlana ShpyroOrkun OzhelvaciÖzlem TüreciZakaria KhondkerWanrong YinYoana ShishkovaSiyue JiaHongxing PanFuzhong PengZhilong MaZhenggang WuXiling GuoYunfeng ShiAlexander MuikUğur ŞahinLi Zhu Feng-Cai Zhu

Published in: Advances in therapy (2022)

NCT04523571, registered August 21, 2020.

Keyphrases

placebo controlled
sars cov
double blind
clinical trial
phase ii
phase iii
respiratory syndrome coronavirus
study protocol
phase ii study
binding protein
randomized controlled trial
radiation therapy